|
SUCLG2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.281390E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.442700E-04 |
| Normal-vs-Stage2 |
7.202600E-01 |
| Normal-vs-Stage3 |
1.137170E-03 |
| Normal-vs-Stage4 |
1.009670E-02 |
| Stage1-vs-Stage2 |
2.691800E-02 |
| Stage1-vs-Stage3 |
6.490600E-01 |
| Stage1-vs-Stage4 |
6.685200E-01 |
| Stage2-vs-Stage3 |
1.989880E-02 |
| Stage2-vs-Stage4 |
3.197800E-02 |
| Stage3-vs-Stage4 |
9.354600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.43769999999088E-05 |
| Normal-vs-AfricanAmerican |
7.462400E-01 |
| Normal-vs-Asian |
7.358800E-03 |
| Caucasian-vs-AfricanAmerican |
3.886200E-02 |
| Caucasian-vs-Asian |
9.662400E-01 |
| AfricanAmerican-vs-Asian |
1.199570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.504100E-03 |
| Normal-vs-Female |
3.042100E-03 |
| Male-vs-Female |
5.350800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.781500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.077890E-03 |
| Normal-vs-Age(61-80Yrs) |
2.360400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.805940E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.056200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.236380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.120200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.567700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.666600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.294800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.292600E-01 |
| Classical-VS-Follicular |
3.32309999995228E-06 |
| Classical-VS-Other |
4.207400E-01 |
| Classical-VS-Normal |
3.12570000005064E-06 |
| Tall-VS-Follicular |
2.522300E-03 |
| Tall-VS-Other |
6.882400E-01 |
| Tall-VS-Normal |
1.667640E-02 |
| Follicular-VS-Other |
3.463800E-01 |
| Follicular-VS-Normal |
2.074400E-01 |
| Other-VS-Normal |
3.508200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.081660E-02 |
| Normal-vs-N1 |
8.45310000000543E-05 |
| N0-vs-N1 |
3.500200E-02 |
|
|
